Merck Sells Merial Stake For $4B To Expedite Merger

Law360, New York (July 30, 2009, 12:47 PM EDT) -- Merck & Co. Inc. has reached a $4 billion cash deal to sell its stake in an animal-health joint venture to Sanofi-Aventis, an agreement aimed at smoothing the path for Merck's planned merger with Schering-Plough Corp.

The animal health company, Merial Ltd., is a 50-50 joint venture between Merck and Sanofi-Aventis. Following the completion of the sale, Sanofi-Aventis will own 100 percent of Merial. Merck's animal health business has been discussed as a possible hurdle to U.S. antitrust regulatory approval of the merger, since Schering also...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.